Can you provide the average price target for OPTINOSE INC stock?
10 analysts have analysed OPTN and the average price target is 9.18 USD. This implies a price decrease of -4.37% is expected in the next year compared to the current price of 9.6.
NASDAQ:OPTN • US68404V2097
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OPTINOSE INC (OPTN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-21 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2025-03-21 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-03-20 | Lake Street | Downgrade | Buy -> Hold |
| 2025-01-16 | Lake Street | Maintains | Buy -> Buy |
| 2025-01-03 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Lake Street | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-18 | Lake Street | Maintains | Buy -> Buy |
| 2024-03-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-11 | HC Wainwright & Co. | Initiate | Buy |
| 2023-08-21 | Lake Street | Initiate | Buy |
| 2023-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2022-11-14 | BMO Capital | Maintains | Outperform |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 76.28M 2.18% | 70.987M -6.94% | 78.226M 10.20% | 102.08M 30.49% | 115.87M 13.51% | 139.37M 20.28% | 187.57M 34.58% | 228.74M 21.95% | 250.26M 9.41% | 272.02M 8.69% | 273.66M 0.60% | |
| EBITDA YoY % growth | -55.37M 15.85% | -22.346M 59.64% | -16.036M 28.24% | 612K 103.82% | 17.442M 2,750.00% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -55.9M 15.88% | -22.748M 59.31% | -16.319M 28.26% | -9.978M 38.86% | -9.014M 9.66% | 3.394M 137.65% | 1.318M -61.17% | 21.785M 1,552.88% | 24.396M 11.99% | 24.313M -0.34% | 23.583M -3.00% | |
| Operating Margin | -73.28% | -32.05% | -20.86% | -9.77% | -7.78% | 2.44% | 0.70% | 9.52% | 9.75% | 8.94% | 8.62% | |
| EPS YoY % growth | -0.89 39.86% | -0.32 64.04% | -2.61 -715.63% | -2.57 1.39% | -1.69 34.41% | -0.35 79.46% | -1.04 -200.00% | 0.45 143.14% | 0.62 38.64% | 0.59 -4.92% | 0.52 -12.07% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.59 21.80% | -0.15 -410.00% | 0.31 1,120.00% |
| Revenue Q2Q % growth | 22.726M 10.91% | 28.152M 25.58% | 32.436M 44.69% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.471M 69.42% | 3.774M 283.92% | 7.65M 2,054.93% |
All data in USD
10 analysts have analysed OPTN and the average price target is 9.18 USD. This implies a price decrease of -4.37% is expected in the next year compared to the current price of 9.6.
OPTINOSE INC (OPTN) will report earnings on 2025-08-06, before the market open.
The consensus EPS estimate for the next earnings of OPTINOSE INC (OPTN) is -0.59 USD and the consensus revenue estimate is 22.73M USD.
The number of analysts covering OPTINOSE INC (OPTN) is 10.